HIGHLIGHTS
- who: Haifa Alfaraidi and M. Constantine Samaan from the University of Maryland, Baltimore, United States have published the research: Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review, in the Journal: (JOURNAL)
- what: Metformin is considered first-line therapy in newly diagnosed pediatric patients with T2D, with or without insulin.
- future: Future research efforts must concentrate on understanding Metformin`s glycemic effects and potential benefits in preventing or decreasing diabetes-related complications and cardiovascular events. Given the high prevalence of PCOS in girls with T2D using Metformin in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.